Thermal sensitisation by lonidamine of human melanoma cells grown at low extracellular pH

International Journal of Hyperthermia

Volumn 30, Issue 1, 2014, Pages 75-78

  Coss, Ronald Allen ^a   Storck, Christopher W ^a   Wells, Tiffany C ^a   Kulp, Kari A ^a   Wahl, Miriam ^b   Leeper, Dennis B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heat shock proteins; Human melanoma cells; Intracellular pH; Lonidamine; Thermal sensitization

Indexed keywords

2,7 BIS(CARBOXYETHYL) 6 CARBOXYFLUORESCEIN; HEAT SHOCK PROTEIN; LONIDAMINE;

ACIDIFICATION; ARTICLE; CELL CULTURE; CELL PH; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; HEATING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOMA CELL; SENSITIZATION; THERMAL SENSITIZATION;

CELL LINE, TUMOR; CELL SURVIVAL; HOT TEMPERATURE; HSP27 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; INDAZOLES; MELANOMA; MONOCARBOXYLIC ACID TRANSPORTERS; RADIATION-SENSITIZING AGENTS;

EID: 84893401443     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.858832     Document Type: Article

References (37)

1. Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, et al. The H-linked monocarboxylate transporter (MCT1/SLC16A1): A potential therapeutic target for high-risk neuroblast-oma. Mol Pharmacol 2006;70:2108-15.
2. Floridi A, Lehninger AL. Action of the antitumor and antisperma-togenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys 1983;226:73-83.
3. 1H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan. NMR Biomed 2012;26:98-105.
4. Kim JH, Kim SH, Alfieri A, Young CW, Silvestrini B. Lonidamine: A hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo. Oncology 1984;41:30-5.
5. Stryker JA, Gerweck LE. Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization. Radiat Res 1988;113: 356-61.
6. Raaphorst GP, Feeley MM, Martin L, Danjoux CE, Maroun J, Desanctis AJ, et al. Enhancement of sensitivity to hyperthermia by lonidamine in human cancer cells. Int J Hyperthermia 1991;7: 763-72.
7. Ben-Yoseph O, Lyons JC, Song CW, Ross BD. Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification. J Neurooncol 1998;36:149-57.
8. Silvestrini B, Hahn GM, Cioli V, De Martino C. Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems. Br J Cancer 1983;47:221-31.
9. Caputo A, Silvestrini B. Lonidamine, a new approach to cancer therapy. Oncology 1984;41:2-6.
10. Citro G, Cucco C, Verdina A, Zupi G. Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line. Br J Cancer 1991;64:534-6.
11. Teicher BA, Herman TS, Holden SA, Epelbaum R, Liu S, Frei III E. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Cancer Res 1991;51:780-4.
12. Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F. Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc) 2003;39:157-74.
13. Gerweck LE. Modification of cell lethality at elevated temperatures. The pH effect. Radiat Res 1977;70:224-35.
14. Freeman ML, Raaphorst GP, Hopwood LE, Dewey WC. The effect of pH on cell lethality induced by hyperthermic treatment. Cancer 1980;45:2291-300.
15. Hofer KG, Mivechi NF. Tumor cell sensitivity to hyperthermia as a function of extracellular and intracellular pH. J Natl Cancer Inst 1980;65:621-5.
16. Chu G, Dewey WC. The role of low intracellular or extracellular pH in sensitization to hyperthermia. Radiat Res 1988;114:154-67.
17. Chu GL, WangZ, Hyun WC, Pershadsingh HA, Fulwyler MJ, Dewey WC. The role of intracellular pH and its variance in low pH sensitization of killing by hyperthermia. Radiat Res 1990;122: 288-93.
18. Lyons JC, Kim GE, Song CW. Modification of intracellular pH and thermosensitivity. Radiat Res 1992;129:79-87.
19. Coss RA, Storck CW, Wachsberger PR, Reilly J, Leeper DB, Berd D, et al. Acute extracellular acidification reduces intracellular pH, 42°C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7. Int J Hyperthermia 2004; 20:93-106.
20. Coss, RA, Storck CW, Daskalakis C, Berd D, Wahl ML. Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. Mol Cancer Ther 2003;2:383-8.
21. Atema A, Buurman KJ, Noteboom E, Smets LA. Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH. Int J Cancer 1993;54:166-72.
22. Jahde E, Glusenkamp KH, Klunder I, Hulser DF, Tietze LF, Rajewsky MF. Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro. Cancer Res 1989;49:2965-72.
23. Jahde E, Glusenkamp KH, Rajewsky MF. Nigericin enhances mafosfamide cytotoxicity at low extracellular pH. Cancer Chemother Pharmacol 1991;27:440-4.
24. Jahde E, Roszinski S, Volk T, Glusenkamp KH, Wiedemann G, Rajewsky MF. Metabolic response of AH13r rat tumours to cyclophosphamide as monitored by pO2 and pH semi-microelec-trodes. Eur J Cancer 1992;29:116-22.
25. Gerweck LE, Vijayappa S, Kozin S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol Cancer Ther 2006;5:1275-9.
26. Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U, et al. Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Cancer Ther 2002;1:617-28.
27. Hill LL, Korngold R, Jaworsky C, Murphy G, McCue P, Berd D. Growth and metastasis of fresh human melanoma tissue in mice with severe combined immunodeficiency. Cancer Res 1991;51: 4937-41.
28. Owen CS, Wahl ML, Leeper DB, Perry HD, Bobyock SB, Russel M, et al. Accurate whole spectrum measurements of intracellular pH and [Na+]. J Fluorescence 1995;5:329-35.
29. Wahl ML, Coss RA, Bobyock SB, Leeper DB, Owen CS. Thermotolerance and intracellular pH in two Chinese hamster cell lines adapted to growth at low pH. J Cell Physiol 1996;166: 438-45.
30. Owen CS, Pooler PM, Wahl ML, Coss RA, Leeper DB. Altered proton extrusion in cells adapted to growth at low extracellular pH. J Cell Physiol 1997;167:397-405.
31. Wahl ML, Pooler PM, Briand P, Leeper DB, Owen CS. Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line. J Cell Physiol 2000;18:373-89.
32. Hickey ED, Weber LA. Modulation of heat-shock polypeptide synthesis in HeLa cells during hyperthermia and recovery. Biochemistry 1982;21:1513-21.
33. Han J-S, Storck CW, Wachsberger PR, Leeper DB, Berd D, Wahl ML, et al. Acute extracellular acidification increases nuclear associated protein levels in human melanoma cells during 42 °C hyperthermia and enhances cell killing. Int J Hyperthermia 2002; 18:404-15.
34. Ben-Horin H, Tassini M, Vivi A, Navon G, Kaplan O. Mechanism of action of the antineoplastic drug lonidamine: P and C nuclear magnetic resonance studies. Cancer Res 1995;55:2814-21.
35. Vivi A, Tassini M, Ben-Horin H, Navon G, Kaplan O. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: P and C nuclear magnetic resonance studies. Breast Cancer Res Treat 1997;43: 15-25.
36. Mardor Y, Kaplan O, Sterin M, Ruiz-Cabello J, Ash E, Roth Y, et al. Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy. Cancer Res 2000;60:5179-86.
37. Coss RA. Inhibiting induction of heat shock proteins as a strategy to enhance cancer therapy. Int J Hyperthermia 2005;21: 695-701.